Global Human Embryonic Stem Cells Market by Country (U.S., China, UK, Japan, Germany), by Application (Regenerative Medicines, Stem Cell Biology Research, Tissue Engineering) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028

Industry Insights

In 2015, the global market for Human Embryonic Stem Cells was worth USD 494.7 Million. These cells are pluripotent and can differentiate into all layers of germ cells. The rising incidence of genetic disorders will likely drive growth.

The projected growth is supported by research that has been done to make them useful for disease eradication. Growth can be induced by controlled differentiation in tissue-committed cells that are co-cultivated with basic fibroblast growing factor.

Market for UK embryonic stem cells, according to application, 2014-2025 (USD million)

The organizations are expected to be active in developing new methods of producing hESCs. Oregon Health and Science University are involved in the development of blastocyst-staged embryos with around 150 cells to supply hESCs.

Stem cells can be used to create liver, nerve and heart tissue. This requires substantial R&D to make sure that the treatment options are safe and effective. However, it can be used in developing biologics for regenerative medicine.

Furthermore, the implementation of ESC-based animal models at academic institutes plays a significant role in projected growth. In 2014, 70% of trials had been sponsored by academic institutions while 30% were sponsored by the private sector.

This vertical has seen rapid advancements, including protocols for directed differentiation and defined culture systems.

Their use is expected to increase demand in the scientific community. These include the presence and production of high levels telomerase and the ability to coaxe into a whole range of tissue types.

Growth is expected to be accelerated by the rapid uptake of ESC-based cell therapy using in vivo as well as in vitro principles. Industry will benefit from research to reduce immunogenicity and induce teratomas.

Implementation remains controversial due to differing views regarding the legal and moral status of embryonic cell lines. These have led to contradictory and provocative claims from both within and outside of the scientific community regarding their biomedical potential.

Market for human embryonic stem cells, by region, 2015. (USD Million).

Application Insights

The largest part of regenerative medicine is responsible for the ability to induce differentiation into many tissues. These cells can be used in therapeutic applications of regenerative medicine.

hESC research has the potential to be a significant tool in treating disorders that are known to cause cellular loss. These conditions include Parkinson's disease and post-myocardial injury, lung disorders, Type 1 diabetes mellitus, and Type 1 diabetes.

The unique properties of hESC-based models allow them to revolutionize drug discovery at the very beginning stages. The provision of physiological models that can be used to model different cell types and their effects on pathology and toxicology is a great way to do this.

Regional Insights

The global market for human embryonic stem cells will be affected by variations in policies around the world. Due to the presence of many prominent entities incorporated in America, North America dominated revenue generation.

Europe will soon be the second largest source of revenue after North America, with hESC research being allowed in Belgium, Finland and the UK. Moreover, the governments of Asian countries support hESC research which in turn boosts growth in this region.

The significant involvement of the Japanese government with the development of cell-line-based therapies is a key factor. This is expected to lead to lucrative growth avenues. Progress is being driven by government-backed efforts to establish a bank of iPSC line banks.

Insights on the Human Embryonic Stem Cells market share

Thermo Fisher Scientific, Inc. is one of the most prominent players in this sector.

CellGenix GmbH. ESI BIO. PromoCell GmbH. Lonza. Kite Pharma. LifeCell. International Stem Cell Corporation.

These companies engage in strategic endeavors to keep market share. Astella Therapeutics, for example, acquired Ocata Therapeutics, which will likely increase its presence in the field of cell therapy.

They also participate in portfolio expansion through the introduction of culture media, which is designed to maximize the growth rate of hESC. Influence on progress is possible through the presence of products in clinical trials.

The Report Covers Certain Segments

This report predicts revenue growth at both the country and regional level. It also provides analysis of the most recent trends and opportunities in each sub-segment from 2014 through 2025. Up Market Research has divided the market for human embryonic stem cell markets based on their application and geographic regions.

• App Outlook (Revenue USD Million; 2014-2025)

  • Regenerative medicine

  • Stem cell biology research

  • Tissue engineering

  • Toxicology testing

• Regional Outlook (Revenue USD Million; 2014-2025)

  • North America

    • The U.S.

    • Canada

  • Europe

    • Germany

    • UK

  • Asia Pacific

    • Japan

    • China

  • Latin America

    • Brazil

  • Middle East and Africa (MEA).

    • South Africa

Up Market Research published a new report titled “Human Embryonic Stem Cells Market research report which is segmented by Country (U.S., China, UK, Japan, Germany), by Application (Regenerative Medicines, Stem Cell Biology Research, Tissue Engineering), By Players/Companies Stem cell biology research, Toxicology testing, Tissue engineering, Regenerative medicine, Application Outlook (Revenue USD Million; 2014 - 2025)Regenerative medicineStem cell biology researchTissue engineeringToxicology testing”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.

Report Scope

The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.

Global Human Embryonic Stem Cells Market Report Segments:

The market is segmented by Country (U.S., China, UK, Japan, Germany), by Application (Regenerative Medicines, Stem Cell Biology Research, Tissue Engineering).

Human Embryonic Stem Cells Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.

Key Benefits for Industry Participants & Stakeholders:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Human Embryonic Stem Cells Market

Overview of the regional outlook of the Human Embryonic Stem Cells Market:

Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.

Highlights of The Human Embryonic Stem Cells Market Report:

1. The market structure and projections for the coming years.
2. Drivers, restraints, opportunities, and current trends of Human Embryonic Stem Cells Market.
3. Historical data and forecast.
4. Estimations for the forecast period 2028.
5. Developments and trends in the market.

                1. U.S.

                2. China

                3. UK

                4. Japan

                5. Germany

                1. Regenerative Medicines

                2. Stem Cell Biology Research

                3. Tissue Engineering

8. Market scenario by region, sub-region, and country.
9. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
10. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
11. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Human Embryonic Stem Cells Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.

How you may use our products:

• Correctly Positioning New Products
• Market Entry Strategies
• Business Expansion Strategies
• Consumer Insights
• Understanding Competition Scenario
• Product & Brand Management
• Channel & Customer Management
• Identifying Appropriate Advertising Appeals

Reasons to Purchase the Human Embryonic Stem Cells Market Report:

• The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
• Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
• Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
• The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
• Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.